Skip to content
healthcare.dev

Memantine and Donepezil Hydrochlorides Extended-release

NDC 73190-004, Memantine and Donepezil, capsule, extended release, from AvKARE.

Product NDC
73190-004
Status
Listed
Labeler
AvKARE
Dosage form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA208328
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/73190-004 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • MEMANTINE HYDROCHLORIDE28 mg/1
  • DONEPEZIL HYDROCHLORIDE10 mg/1

Pharmacologic classes

Cholinesterase Inhibitor [EPC]; Cholinesterase Inhibitors [MoA]; N-methyl-D-aspartate Receptor Antagonist [EPC]; NMDA Receptor Antagonists [MoA]

Package NDCNDC-11Package
73190-004-307319000043030 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (73190-004-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/2d821427-34ca-3c5d-e063-6394a90a9013

Use it

Look up 73190-004 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/73190-004 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 73190-004. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.